219 related articles for article (PubMed ID: 31021924)
1. Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease.
Brenner EJ; Long MD
Curr Opin Gastroenterol; 2019 Jul; 35(4):330-336. PubMed ID: 31021924
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy.
Marzano AV; Borghi A; Stadnicki A; Crosti C; Cugno M
Inflamm Bowel Dis; 2014 Jan; 20(1):213-27. PubMed ID: 24105394
[TBL] [Abstract][Full Text] [Related]
3. Ustekinumab for the treatment of paradoxical skin reactions and cutaneous manifestations of inflammatory bowel diseases.
Wu J; Smogorzewski J
Dermatol Ther; 2021 May; 34(3):e14883. PubMed ID: 33594811
[TBL] [Abstract][Full Text] [Related]
4. Management of cutaneous side effects of inflammatory bowel disease therapy: A dermatologic viewpoint.
Lee J; Lemons N; Lorenze A; Chowdhary TS; Zinn Z; Gayam S
J Gastroenterol Hepatol; 2021 Dec; 36(12):3278-3285. PubMed ID: 34139789
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy.
Marzano AV; Borghi A; Meroni PL; Crosti C; Cugno M
Autoimmunity; 2014 May; 47(3):146-53. PubMed ID: 24437626
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease: Joint Management in Gastroenterology and Dermatology.
Sánchez-Martínez MA; Garcia-Planella E; Laiz A; Puig L
Actas Dermosifiliogr; 2017 Apr; 108(3):184-191. PubMed ID: 27576452
[TBL] [Abstract][Full Text] [Related]
7. Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
Anderson A; Ferris LK; Click B; Ramos-Rivers C; Koutroubakis IE; Hashash JG; Dunn M; Barrie A; Schwartz M; Regueiro M; Binion DG
Dig Dis Sci; 2018 Oct; 63(10):2729-2739. PubMed ID: 29713987
[TBL] [Abstract][Full Text] [Related]
8. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease.
Olpin JD; Sjoberg BP; Stilwill SE; Jensen LE; Rezvani M; Shaaban AM
Radiographics; 2017; 37(4):1135-1160. PubMed ID: 28548906
[TBL] [Abstract][Full Text] [Related]
9. Skin side effects of inflammatory bowel disease therapy.
Torres J; Buche S; Delaporte E; Colombel JF
Inflamm Bowel Dis; 2013 Apr; 19(5):1086-98. PubMed ID: 23474780
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
[TBL] [Abstract][Full Text] [Related]
11. Dermatologic manifestations of inflammatory bowel disease: a review.
Keyal U; Liu Y; Bhatta AK
Discov Med; 2018 May; 25(139):225-233. PubMed ID: 29906405
[TBL] [Abstract][Full Text] [Related]
12. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
Kujundzić M
Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
[TBL] [Abstract][Full Text] [Related]
13. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
Larsen S; Bendtzen K; Nielsen OH
Ann Med; 2010 Mar; 42(2):97-114. PubMed ID: 20166813
[TBL] [Abstract][Full Text] [Related]
14. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
Apgar JT
Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
[TBL] [Abstract][Full Text] [Related]
15. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
[TBL] [Abstract][Full Text] [Related]
16. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease.
Brown SR; Coviello LC
Surg Clin North Am; 2015 Dec; 95(6):1245-59, vii. PubMed ID: 26596925
[TBL] [Abstract][Full Text] [Related]
17. Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases.
Solitano V; D'Amico F; Correale C; Peyrin-Biroulet L; Danese S
Br Med Bull; 2020 Dec; 136(1):107-117. PubMed ID: 33200781
[TBL] [Abstract][Full Text] [Related]
18. Current clinical issue of skin lesions in patients with inflammatory bowel disease.
Iida T; Hida T; Matsuura M; Uhara H; Nakase H
Clin J Gastroenterol; 2019 Dec; 12(6):501-510. PubMed ID: 30838512
[TBL] [Abstract][Full Text] [Related]
19. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management.
Garber A; Regueiro M
Curr Gastroenterol Rep; 2019 May; 21(7):31. PubMed ID: 31098819
[TBL] [Abstract][Full Text] [Related]
20. Extraintestinal manifestations of inflammatory bowel disease.
Urlep D; Mamula P; Baldassano R
Minerva Gastroenterol Dietol; 2005 Jun; 51(2):147-63. PubMed ID: 15990704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
